ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676769 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676769; 2) Community: the network communities that were significantly associated with the response to NSC 676769; 3) Molecule: the relationships between components within communities and NSC 676769; 4) MDR: the compounds that were significantly associated with the NSC 676769.

NSC Compound Enrichment Correlation
NSC 68091 WLN: WS3&1U1SW3 -T 4.69612670285786e-005 0.70045159
NSC 683516 Null 4.69612670285786e-005 0.42819015
NSC 737733 1N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-[4-(2-pheridyl)hex ahydro-1-pyrazinyl]acetamide 4.69612670285786e-005 0.41734529
NSC 637140 9-N-(N'-bis-chloroethyl-N-1,5-diaminopentyl)-2-methoxy acridine, dihydrochloride 5.30973832161747e-005 0.43328251
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 5.30973832161747e-005 0.61459128
NSC 718730 Null 5.30973832161747e-005 0.58212591
NSC 760979 Null 5.30973832161747e-005 0.28188948
NSC 745449 Null 5.35289872404964e-006 0.62626203
NSC 113951 6-Bromotoyocamycin 6.70485325419768e-005 0.50577689
NSC 626162 Discorhabdin C . TFA 6.74487631170136e-005 0.77066591
Total:123  Current:122    [First] [Prev] [Next] [Last]